84380-01-8 | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$15.00	$10.00
1g	95%	in stock	$16.00	$11.00
5g	95%	in stock	$39.00	$27.00
10g	95%	in stock	$49.00	$34.00
25g	95%	in stock	$98.00	$69.00
100g	95%	in stock	$315.00	$221.00
250g	95%	in stock	$571.00	$400.00
500g	95%	in stock	$1,070.00	$749.00

Description

• Catalog Number: AI56940
• Chemical Name: (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol
• CAS Number: 84380-01-8
• Molecular Formula: C12H16O7
• Molecular Weight: 272.25124
• MDL Number: MFCD09838262
• SMILES: OC[C@H]1O[C@H](Oc2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)O

Computed Properties

• Complexity: 279
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 5
• Heavy Atom Count: 19
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 5
• Rotatable Bond Count: 3
• XLogP3: -0.7

Literature

• Arbutin's suppression of cryodamage in goat sperm and its mechanism of cryoprotection.

  Theriogenology 20110801

• Beta-cyclodextrin conjugates with glucose moieties designed as drug carriers: their syntheses, evaluations using concanavalin A and doxorubicin, and structural analyses by NMR spectroscopy.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20080501

• Arbutin blocks defects in the ripple phase of DMPC bilayers by changing carbonyl organization.

  Chemistry and physics of lipids 20070501

• Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products.

  Bioorganic & medicinal chemistry 20070301

• Synthesis of hydroquinone-alpha-glucoside by alpha-glucosidase from baker's yeast.

  Biotechnology letters 20050401

• Syntheses of arbutin-alpha-glycosides and a comparison of their inhibitory effects with those of alpha-arbutin and arbutin on human tyrosinase.

  Chemical & pharmaceutical bulletin 20030701

• The effect of arbutin on membrane integrity during drying is mediated by stabilization of the lamellar phase in the presence of nonbilayer-forming lipids.

  Chemistry and physics of lipids 20010501